California · Q0220

Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise in California

California Medicare Avg
$0.01
0% below national avg
National Medicare Avg
$0.01
All states combined
Billed Charge (CA)
$1.28
What providers submit
Est. Commercial (CA)
$0.02
National avg: $0.02
Est. Cash / Self-Pay (CA)
$0.36
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

11
Services in CA
5
Providers
N/A
Min Payment
N/A
Max Payment

California Pricing in Context

In California, CPT code Q0220 (Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise) carries an average Medicare payment of $0.01 — 0% below the national benchmark of $0.01. 5 providers across the state submitted claims for this procedure in 2023, performing 11 total services. Individual payments in CA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in California is $1.28, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because California sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Temporary Codes procedures, the estimated commercial insurance price in California lands near $0.02, with self-pay cash prices typically around $0.36. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise cost in California?

The average Medicare payment for Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise in California is $0.01, which is 0% below the national average of $0.01. Providers in CA typically bill $1.28 for this procedure.

What does Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise cost with insurance in California?

With commercial insurance in California, Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise costs an estimated $0.02. Without insurance, the estimated cash price is $0.36. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise in California?

5 providers in California billed Medicare for Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise in 2023, performing 11 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise cheaper in California than the national average?

Yes — Injection, Tixagevimab And Cilgavimab, For The Pre-Exposure Prophylaxis Only, For Certain Adults And Pediatric Individuals (12 Years Of Age And Older Weighing At Least 40kg) With No Known Sars-Cov-2 Exposure, Who Either Have Moderate To Severely Compromise costs 0% below the national average in California. The state average Medicare payment is $0.01 compared to $0.01 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial